Navigation Links
Excaliard Pharmaceuticals Appoints Thomas Wiggans to Chairman of the Board
Date:10/18/2010

CARLSBAD, Calif., Oct. 18 /PRNewswire/ -- Excaliard Pharmaceuticals, Inc. announced today the appointment of Thomas G. Wiggans as Chairman of its Board of Directors. Mr. Wiggans brings to the role more than 30 years of experience in successfully developing and commercializing drugs with several notable successes in the dermatology field.  Excaliard Pharmaceuticals, Inc. is a biotechnology company focused on the clinical development and commercialization of novel drugs for the amelioration of skin scarring and other fibrotic disorders.

"We are delighted to have Mr. Wiggans join Excaliard," commented Gordon Foulkes, President of Excaliard, and Managing Director of RiverVest Venture Partners. "Tom has successfully led dermatology companies, such as Connetics and Peplin, and his guidance in Excaliard's growth will be invaluable."

"Excaliard has made impressive clinical progress in advancing its lead product EXC-001 through three Phase II clinical studies in skin scarring," commented Mr. Wiggans. "I am looking forward to working with the Excaliard team to bring EXC-001 and the company's product pipeline forward."

In August 2010, Excaliard announced positive results from its Phase 2 clinical trial of EXC 001. Results showed that EXC 001 treatment significantly reduced scar severity in subjects undergoing an elective abdominoplasty compared to placebo at 12 weeks post surgery. The final analysis for this study will be conducted 24 weeks after surgery. The data for this study and two additional skin scarring Phase 2 studies will be available later in 2010.

Most recently Mr. Wiggans was Chairman of the Board of Directors and Chief Executive Officer of Peplin, Inc., which was acquired in 2009 by LEO Pharma of Copenhagen, Denmark. Prior to that, he served as CEO of Connetics Corporation from 1994 until 2006, when the company was acquired by Stiefel Laboratories. From 1992 to 1994, Mr. Wiggans served as President and Chief Opera
'/>"/>

SOURCE Excaliard Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Excaliard Announces Positive Data From Phase 2 Clinical Trial of Its Anti-Scarring Drug, EXC 001
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 23, 2014   Assurex Health, a personalized ... healthcare providers for behavioral health and chronic pain ... million in equity financing from new and existing ... President and Chief Executive Officer. The ... of Assurex Health,s GeneSight ®  products.  ...
(Date:12/24/2014)... BARBARA, Calif. , Dec. 23, 2014 In ... Junior Doctors, Association of Sierra Leone , ... Sierra Leone for the treatment of local health ... While a new dedicated Ebola care center was constructed ... virus, the facility is not available for local Sierra Leonean ...
(Date:12/22/2014)... 22, 2014 NxStage Medical, Inc. (NASDAQ: ... dialysis products, announced today that the U.S. Food ... One™ to perform hemodialysis overnight while the patient ... hemodialysis. NxStage,s® System One is the first and ... this indication. Home nocturnal hemodialysis ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3
... New Study Results Show Antibodies Against Cancer-Causing Virus,Types ... Times Greater Than Natural,Infection Levels, CHICAGO, June 05, ... at 18 months after the first of a ... 55 vaccinated with the GlaxoSmithKline,(GSK) cervical cancer candidate ...
... Elixir,Pharmaceuticals, Inc., announced today new preclinical data,confirming ... regulating,metabolism, decreasing body weight and managing blood ... during ENDO 07, The,Endocrine Society's 89th Annual ... focused on the development of drugs to ...
Cached Medicine Technology:Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 2Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 3Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 4Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 5Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 2Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 3Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 4
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... found that the rates have increased among those who take the ... children immunized with the three-in-one MMR jab in Scotland. But the ... 95% by the age of two. But there was a 0.7% ... the vaccines association with the childhood autism disease. , ...
... decrease in chicken and egg prices have forced a Kolkata ... consuming pesticide. // The huge debts is said to have ... an owner of one of the biggest poultry farms in ... the chickens were found to be affected by Ranikhet disease. ...
... St. Louis say that a noninvasive approach towards assessing ... for cystic fibrosis and pneumonia. // Positron emission tomography ... in the lungs of healthy volunteers. ,"Until ... drug decreased lung inflammation, the options for specifically measuring ...
... group jogging or jogging with a friend will be more ... ,Researchers led by Professor Elizabeth Gould at Harvard University compared ... exercise in a group and found that contrary to accepted ... reported online edition of Daily Mail. ,The researchers ...
... bacteria belonging to the Legionella family, Legionella pneumophilia. // ... her 50s and the other in her 70s. They were ... , New South Wales (NSW) health officials are investigating an ... had been to the Chatswood's shopping area. The disease results ...
... record system, designed to connect up 50 million patients' records, ... trouble, according to reports. // The National Audit Office has ... rounds that the new NHS system might have thrown patients ... The switch to the new system, a modernization plan for ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: